Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEDESTAL EFS: LTO-WB vs Conventional Blood Products
NCT06809010Recruiting
- Sponsor
- Etablissement Français du Sang
- Start
- Mar 2025
- Primary completion
- Feb 2028
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of Low Titer O Whole Blood in hemorrhage (2 arms), sponsored by Etablissement Français du Sang. Primary endpoint: Assessment of the platelet-related inflammatory potential of blood products throughout storage at Day 42. Started Mar 2025; status: recruiting.
02
Drugs
Low Titer O Whole Blood
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT06809010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06809010.